Phoenix Biotech Acquisition OverviewPhoenix Biotech Acquisition Other Income Expense Net
Other Income/Expense Net for PBAX.
Quarterly Other Income/Expense
-$1.04M
↓ 106.54% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$77.60M
↓ 1075.12% YoY
Trailing 12 months ending Mar 31, 2026